Interaction between cardiac sympathetic drive and heart rate in heart failure: Modulation by adrenergic receptor genotype

Journal of the American College of Cardiology

Volumn 44, Issue 10, 2004, Pages 2008-2015

  Kaye, David M ^a,c   Smirk, Belinda ^a   Finch, Samara ^a   Williams, Carolyn ^b   Esler, Murray D ^c  

^a Wynn Dept of Metabolic Cardiology   (Australia)

^b Australia   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMIODARONE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NORADRENALIN; PRESYNAPTIC RECEPTOR; TRACER;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEART FAILURE; HEART MUSCLE; HEART RATE; HUMAN; INCIDENCE; MALE; MEASUREMENT; NERVE ENDING; NORADRENALIN RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE;

ADULT; AGED; DNA PRIMERS; FEMALE; GENOTYPE; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-2; SEVERITY OF ILLNESS INDEX;

EID: 8144221767     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.058     Document Type: Article

References (25)

1. J. Cohn, T. Levine, M Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
2. D.M. Kaye, J. Lefkovits, G. Jennings, P. Bergin, A. Broughton, M.D. Esler Adverse consequences of increased cardiac sympathetic activity in the failing human heart J Am Coll Cardiol 26 1995 1257 1263
3. M. Bristow Antiadrenergic therapy of chronic heart failure: surprises and new opportunities Circulation 107 2003 1100 1102
4. P.A. Poole-Wilson, K. Swedberg, J.G Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
5. R.P. Xiao, H. Cheng, Y.Y. Zhou, M. Kuschel, E.G. Lakatta Recent advances in cardiac β2-adrenergic signal transduction Circ Res 85 1999 1092 1100
6. M.R. Bristow, R. Ginsberg, V Umans β1- and β2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure Circ Res 59 1986 297 309
7. H. Majewski Modulation of norepinephrine release through activation of presynaptic β-adrenoceptors J Auton Pharm 3 1983 47 60
8. M. Brede, F. Wiesmann, R Jahns Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure Circulation 106 2002 2491 2496
9. K.M. Small, L.E. Wagoner, A.M. Levin, S.L. Kardia, S.B. Liggett Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure N Engl J Med 347 2002 1135 1142
10. K.M. Small, D.W. McGraw, S.B. Liggett Pharmacology and physiology of human adrenergic receptor polymorphisms Annu Rev Pharmacol Toxicol 43 2003 381 411
11. D.M. Kaye, B. Smirk, C. Williams, G. Jennings, M. Esler, D. Holst Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure Pharmacogenetics 13 2003 379 382
12. M. Esler, G. Jennings, G. Lambert, I. Meredith, M. Horne, G. Eisenhofer Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions Physiol Rev 70 1990 963 985
13. M. Borjesson, Y. Magnusson, A. Hjalmarson, B. Andersson A novel polymorphism in the gene coding for the β1-adrenergic receptor associated with survival in patients with heart failure Eur Heart J 21 2000 1853 1858
14. K.M. O'Shaughnessy, B. Fu, C. Dickerson, D. Thurston, M.J. Brown The gain of function variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects Clin Sci 99 2000 233 238
15. C allelic variants and personality factors Am J Med Genetics 114 2002 649 651
16. S.B. Liggett, L.E. Wagoner, L.L Craft The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure J Clin Invest 102 1998 1534 1539
17. B. Rundqvist, M. Elam, Y. Bergmann-Sverrisdottir, G. Eisenhofer, P. Friberg Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure Circulation 95 1997 169 175
18. V. Dishy, G.G. Sofowora, H.G Xie The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization N Engl J Med 345 2001 1030 1035
19. L.E. Wagoner, L.L. Craft, B Singh Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure Circ Res 86 2000 834 840
20. S.A. Green, J. Turki, M. Innis, S.B. Liggett Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 1994 9414 9419
21. A. Aggarwal, M.D. Esler, F. Socratous, D.M. Kaye Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure J Am Coll Cardiol 37 2001 1246 1251
22. K.M. Small, S.L. Forbes, F.F. Rahman, K.M. Bridges, S.B. Liggett A four amino acid deletion polymorphism in the third intracellular loop of the human α2C-adrenergic receptor confers impaired coupling to multiple effectors J Biol Chem 275 2000 23059 23064
23. G.E. Newton, E.R. Azevedo, J.D. Parker Inotropic and sympathetic responses to the intracoronary infusion of a β2-receptor agonist: a human in vivo study Circulation 99 1999 2402 2407
24. T.W. Lameris, S. de Zeeuw, D.J Duncker Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release Circulation 106 2002 860 865
25. D.M. Kaye, G.W. Lambert, J. Lefkovits, M. Morris, G. Jennings, M.D. Esler Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure J Am Coll Cardiol 23 1994 570 578